NFKB1 and chronic kidney disease: These CKD-related biochemical changes are significantly counteracted by vitamin D3 treatment, which induces a decrease in the elevated IL-6 mRNA expression, positively affects the activity of NFκB, and normalizes the parameters associated with the eNOS system.